Results Thru Strategy
Results Thru Strategy and ICR Announce Strategic Partnership
April 29, 2024 10:30 ET | Integrated Corporate Relations
Results Thru Strategy and ICR Announce Strategic Partnership
Empowering Families:
Empowering Families: May Recognized as Women's Health Awareness Month with a Focus on Pediatric Gastroenterology
April 29, 2024 08:40 ET | GI Alliance
Frisco, TX, April 29, 2024 (GLOBE NEWSWIRE) -- As we approach Women’s Health Awareness Month in May, GI Alliance – the leading physician-owned and -led network of gastroenterology practices in the...
GI Alliance Supports
GI Alliance Supports Women’s Health Awareness Month: A Focus on Colorectal Health
April 29, 2024 08:35 ET | GI Alliance
Glenview, IL, April 29, 2024 (GLOBE NEWSWIRE) -- As we approach Women’s Health Awareness Month in May, GI Alliance – the leading physician-owned and -led network of gastroenterology practices in the...
ibn_169.jpg
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Steffan Dalsgaard, CEO of Golden Triangle Ventures Inc.
April 29, 2024 08:17 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, April 29, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce...
MannkindLogoStackedPreferd.jpg
MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung Disease
April 29, 2024 06:05 ET | MannKind
MANNKIND ANNOUNCES IND CLEARANCE FROM U.S. FDA TO START PHASE 3 STUDY OF CLOFAZIMINE INHALATION SUSPENSION FOR NTM LUNG DISEASE
ID Logo Medium PNG (Transparent Background).png
InterDigital’s Doug Castor Elected Co-Chair of the ATIS Next G Alliance Steering Group
April 29, 2024 04:00 ET | InterDigital, Inc.
InterDigital’s Doug Castor elected to co-chair the ATIS Next G Alliance Steering Group
Tevogen Logo Notified.png
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
April 26, 2024 09:23 ET | Tevogen Bio Inc
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
Rakshit Choudhary, co-CEO of Deriv
Rakshit Choudhary : de directeur des opérations à co-PDG de Deriv
April 26, 2024 05:41 ET | Deriv Group
Rakshit Choudhary, promu co-PDG, collaborera avec le fondateur et PDG Jean-Yves SireauDeriv donne un coup de neuf à son modèle de leadership à l’approche de la célébration de son 25e anniversaire ...
Rakshit Choudhary, co-CEO de Deriv
Deriv promueve a Rakshit Choudhary de COO a co-CEO
April 26, 2024 05:41 ET | Deriv Group
Rakshit Choudhary es nombrado co-CEO, junto con el fundador y CEO Jean-Yves Sireau.Deriv renueva su modelo de liderazgo para celebrar su vigésimo quinto aniversario. Rakshit Choudhary, co-CEO de...
Rakshit Choudhary, co-CEO of Deriv
Deriv promotes Rakshit Choudhary from COO to co-CEO
April 26, 2024 05:41 ET | Deriv Group
Rakshit Choudhary promoted to co-CEO, partnering with Founder and CEO Jean-Yves Sireau.